Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2008-09-09
2008-09-09
Kim, Jennifer (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S558000
Reexamination Certificate
active
11099134
ABSTRACT:
Methods, pharmaceutical compositions, and compounds for reducing body weight, modulating body lipid metabolism, and reducing food intake in mammals are provided. The compounds of the invention include fatty acid ethanolamide compounds, homologues and analogs of which the prototype is the endogenous fatty acid ethanolamide, oleoylethanolamide.
REFERENCES:
patent: 5506224 (1996-04-01), Della Valle et al.
patent: 5554646 (1996-09-01), Cook et al.
patent: 5602164 (1997-02-01), Shinitzky et al.
patent: 5618955 (1997-04-01), Mechoulam et al.
patent: 5631297 (1997-05-01), Pate et al.
patent: 5679667 (1997-10-01), Della Valle et al.
patent: 5803916 (1998-11-01), Hanun et al.
patent: 5847008 (1998-12-01), Doebber et al.
patent: 5859051 (1999-01-01), Adams et al.
patent: 5925672 (1999-07-01), Piomelli et al.
patent: 5962012 (1999-10-01), Lin et al.
patent: 5985282 (1999-11-01), Haveson
patent: 6068976 (2000-05-01), Briggs et al.
patent: 6090836 (2000-07-01), Adams et al.
patent: 6090839 (2000-07-01), Adams et al.
patent: 6096784 (2000-08-01), Lerner et al.
patent: 6160000 (2000-12-01), Adams et al.
patent: 6200998 (2001-03-01), Sahoo et al.
patent: 6261595 (2001-07-01), Stanley et al.
patent: 6271015 (2001-08-01), Gilula et al.
patent: 6274608 (2001-08-01), Sauerberg et al.
patent: 6344474 (2002-02-01), Maruani et al.
patent: 6348498 (2002-02-01), Calignano et al.
patent: 6359010 (2002-03-01), Geracioti, Jr. et al.
patent: 2002/0035150 (2002-03-01), Piomelli
patent: 2003/0041340 (2003-02-01), Cravatt
patent: 2003/0149082 (2003-08-01), Makriyannis
patent: 2003/0195226 (2003-10-01), Sit et al.
patent: 0 225 303 (1987-06-01), None
patent: 0 724 842 (1996-08-01), None
patent: WO 94/12466 (1994-06-01), None
patent: WO 97/27857 (1997-08-01), None
patent: WO 97/28149 (1997-08-01), None
patent: WO 97/36579 (1997-10-01), None
patent: WO 98/20119 (1998-05-01), None
patent: WO 98/24396 (1998-06-01), None
patent: WO 99/60987 (1999-12-01), None
patent: WO 01/24645 (2001-04-01), None
patent: WO 02/078746 (2002-10-01), None
patent: WO 02/080860 (2002-10-01), None
patent: WO 02/080903 (2002-10-01), None
patent: WO 2004/045307 (2004-06-01), None
Ahern, G. P. “Activation of TRPV1 by the satiety factor oleoylethanolamide” J. Biological Chemistry 278(33):30429-30434 (Aug. 15, 2003).
Auboeuf, D. et al., “Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferators-activated receptors and liver X receptor-.alpha. in humans” Diabetes 46:1319-1327 (1997).
Bachur, N. R., et al., “Fatty Acid Amides of Ethanolamine in Mammalian Tissues,” J. Biol. Chem., (1965), vol. 240, No. 3, pp. 1019-1024.
Berdyshev, E., et al., “Stress-induced generation of IN-acylethanolamines in mouse epidermal JB6 P+ cells,” Biochem, J., (2000), vol. 346, pp. 369-374.
Boger, D. L., et al., “Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide,” PNAS, (2000), vol. 97, No. 10, pp. 5044-5049.
Cadas, H., et al., “Biosynthesis of an Endogenous Cannabinoid Precursor in Neurons and its Control by Calcium and cAMP,” J. NeuroSci., (1996), vol. 16, pp. 3934-3942.
Cadas, H., et al., “Occurrence and Biosynthesis of Endogenous Cannabinoid Precursor, N-Arachidonoyl Phosphatidylethanolamine, in Rat Brain,” J. Neurosci., (1997), vol. 17, No. 4, pp. 1226-1242.
Calignano, A. et al., “Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide” Eur. J. Pharmacol, 419(2-3):191-8 (2001).
Calignano, A., et al., “Control of pain initiation by endogenous cannabinoids,” Nature, (1998), vol. 394, pp. 277-281.
Calignano, et al.; “Control of pain initiation by endogenous cannabinoids”; Nature; Jul. 16, 1998; vol. 394; pp. 277-281; Macmillan Publishers Ltd.
Calignano. A., et al., “Bidirectional control of airway responsiveness by endogenous cannabinoids,” Nature, (2000), vol. 408, pp. 96-101.
Chapman, K.D., “Emerging physiological roles for N-acylphosphatidylethanolamine metabolism in plants: signal transduction and membrane protection,” Chem. Phys. Lipids, (2000), vol. 108:22, pp. 221-229.
Conti, S., et al., “Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat,” British Journal of Pharmacology, (2002), vol. 135, pp. 181-187.
Crabatt, B. F., et al., “Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling inmice lacking fatty acid amide hydrolase,” PNAS, (2001), vol. 98, No. 16, pp. 9371-9376.
Desamaud, F., et al., “Anandamide Amidohydrolase Activity in Rat Brain Microsomes,” J. Biol. Chem., (1995), vol. 270, No. 11, pp. 6030-6035.
Desvergne, B. et al., “Peroxisome proliferators-activated receptors: Nuclear control of metabolism” Endocrine Rev. 20(5):649-688 (1999).
Devane, W. A., et al., “Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor,” Science, (1992), vol. 258, pp. 1946-1949.
Di-Tomaso, E. et al., “Endogenous lipids that activate cannabinoid receptors. Formation and inactivation” Adv. Exp. Med. Biol. 407:335-40 (1997).
Forman, B. M., et al., “Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferators-activated receptors .alpha. and .delta.,” PNAS, (1997), vol. 94, pp. 4312-4317.
Fu, J. et al., “Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha” Nature 425(6953):90-3 (2003).
Gaetani, S. et al., “Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide” Neuropsychopharm. 28(7):1311-6 (2003).
Giuffrida, A. et al., “Purification and High-Resolution Analysis of Anandamide and Other Fatty Acylethanolamides,” in S. G. Laychock, ed. and R. P. Rubin, ed. Lipid Second Messengers, CRC Press LLC, Boca Raton, Florida, (1999), pp. 113-133.
Giuffrida, A., et al., “Dopamine activation of endogenous cannabinoid signaling in dorsal striatum,” Nat. Neurosci., (1999), vol. 2, No. 4, pp. 358.
Giuffrida, A., et al., “Mechanisms of Endocannabinoid Inactivation: Biochemistry and Pharmacology,” J. Pharmacol. Exp. Ther., (2001), vol. 298, No. 1, pp. 7-14.
Giuffrida, A., et al., “Quantification of Bioactive Acylethanolamides in Rat Plasma by Electrospray Mass Spectrometry,” Anal. Biochem., (2000), vol. 280, pp. 87-93.
Gomez, R. et al., “A peripheral mechanism for CB 1 cannabinoid receptor-dependent modulation of feeding” J. Neurosci, 22(21):9612-7 (2002).
Griffin, G., et al., “Cloning and Pharmacological Characterization of the Rat CB.sub.2 Cannabinoid Receptor,” J. Pharmacol. Exp. Ther., (2000), vol. 292, No. 3, pp. 886-894.
Guiffrida, A., et al., “Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma,” FEBS Letters, (1998), vol. 422, pp. 373-376.
Kersten, S. et al., “Roles of PPARs in health and disease” Nature 405:421-424 (2000).
Khanolkar, A., et al., “Structure-Activity Relationships of Anandamide, and Endogenous Cannabinoid Ligand,” Life Sci., (1999), vol. 65, No. 6/7, pp. 607-616.
Kliewer, S. et al., “Peroxisome proliferators-activated receptors: from genes to physiology” Recent Prog Horm Res 56:239-63 (2001).
Loviscach, M. et al., “Distribution of peroxisome proliferators-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action” Diabetologia 43(3):304-11 (2000).
Marzo, V. D., et al., “Formation and inactivation of endogenous cannabinoid anandamide in central neurons,” Nature, (1994), vol. 372, pp. 686-691.
Mechoulam, R. et al., “A hunger for cannabinoids” Nature 410:763-765 (2001).
Memon, R. et al.,
de Fonseca Fernando Rodriguez
Piomelli Daniele
Kim Jennifer
The Regents of the University of California
Townsend and Townsend / and Crew LLP
LandOfFree
Methods, compounds, and compositions for reducing body fat... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods, compounds, and compositions for reducing body fat..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods, compounds, and compositions for reducing body fat... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3914649